FDA approves Lupin’s Flagyl generic

Press enter to search
Close search
Open Menu

FDA approves Lupin’s Flagyl generic

By David Salazar - 09/14/2017

SILVER SPRING, Md. — The Food and Drug Administration has approved Lupin’s generic of Flagyl (metronidazole) tablets, the company announced Wednesday. The drug is indicated to treat various infections caused by bacteria and other infectious organisms.


Lupin’s generic will be available in 250- and 500-mg dosage strength tablets. The drug had U.S. sales of $44.1 million for the 12 months ended June 2017, according to QuintilesIMS data.


Related Topics